WeVote
Log In

Bill

Bill

HB 152

MEDICALLY ASSISTED TREATMENT FOR JUVENILES

2025 Regular Session Introduced by Marianna Anaya and 1 co-sponsor

New Mexico bill authorizes medically assisted opioid treatment for juveniles, expanding access to FDA-approved medications addressing adolescent addiction crisis.

action postponed indefinitely
#health&healthfacilities
0
WeVote Research Nonpartisan
Bill Summary · HB 152

Legislative bill overview

HB 152 would establish medically assisted treatment (MAT) programs for juveniles in New Mexico, allowing minors to access medications like methadone and buprenorphine for opioid use disorder. The bill creates regulatory frameworks and funding mechanisms to support these treatment services within the state's healthcare system.

Why is this important

Opioid addiction among adolescents has increased significantly, and MAT is evidence-based treatment that reduces overdose deaths and improves recovery outcomes. Current law in many states restricts or prohibits juvenile access to these medications, leaving young people with limited treatment options despite medical recommendations from organizations like the American Academy of Pediatrics.

Potential points of contention

  • Parental consent and authority: Questions about whether minors can access MAT without parental knowledge/consent, and how this balances adolescent autonomy with parental rights
  • Medication substitution concerns: Some argue MAT replaces one addiction with another rather than achieving abstinence, though medical evidence supports its effectiveness
  • Implementation costs: Significant funding required for training providers, establishing clinics, and ongoing services during a budget-constrained period (note: bill reached appropriations committee)

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.